glp 1 drugs risks America's Poison Centers GLP-1 Drugs & What They

For many years, scientists like Professor Jens Juul Holst, characterized the function of a gut hormone called GLP-1

Off-label prescribing for weight loss without a diabetes diagnosis triggers an automatic denial

GLP-1 Pipeline In November 2023, the FDA approved Zepbound (tirzepatide), a GLP-1 antagonist and GIP dual agonist with superior weight loss efficacy compared to its competitors

For patients primarily seeking weight management, either with or without type 2 diabetes, higher-dose formulations such as semaglutide 2.4 mg (Wegovy) or liraglutide 3 mg (Saxenda) may be more appropriate

From manufacturing to last-mile delivery, these drugs must be protected from temperature excursions that could render them ineffective

Barriers to insulin injection therapy: Patient and health care provider perspectives